Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Budesonide MDI (PT008) in mild to moderate persistent asthma
NCT02105012Phase 2Completed
- Sponsor
- Pearl Therapeutics
- Start
- Apr 2014
- Primary completion
- Sep 2015
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 2 trial of budesonide in asthma, sponsored by Pearl Therapeutics. Started Apr 2014; status: completed.
02
Drugs
budesonide
03
Conditions
asthma
Beyond the preview
Go deeper on NCT02105012.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT02105012.